ACTRN12615001265561
Recruiting
Phase 1
In patients with Non-Small Cell Lung Cancer (NSCLC) is Pentixafor-PET a more accurate imaging test than FDG-PET for local staging and identifying sites of metastatic disease?
Oceanic Molecular Imaging0 sites30 target enrollmentNovember 19, 2015
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- on-small cell lung cancer
- Sponsor
- Oceanic Molecular Imaging
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •a.Histological diagnosis of NSCLC.
- •b.Requires 18F\-FDG PET/CT as part of routine work\-up for diagnosis and staging.
- •c.Competent to provide informed consent
- •d.Not pregnant or breastfeeding
Exclusion Criteria
- •Pregnant or breastfeeding
- •Lack of indication or contraindication to FDG PET
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
tritional Assessment in Non-small Cell lung cancer patientslungcancerNon Small Cell Lung Cancer10038666NL-OMON50451Antoni van Leeuwenhoek Ziekenhuis100
Completed
Not Applicable
Benefits of home-based multidisciplinaryrehabilitation in non small cell lung canceron small cell lung cancerNon small cell lung cancerCancer - Lung - Non small cellPhysical Medicine / Rehabilitation - PhysiotherapyACTRN12614001268639Professor Linda Denehy92
Completed
Not Applicable
Prognostic factors of non-small cell lung cancer patients with brain metastasison-small cell lung cancerJPRN-UMIN000030313KKR Sapporo Medical Center300
Completed
Not Applicable
Supportive treatment in non-small cell lung canceron small cell lung cancerCancerNon small cell lung cancerISRCTN96733516Medical Research Council (MRC) (UK)230
Suspended
Phase 3
EGF vaccine- Advanced Lung tumorson Small Cells Lung CancerRPCEC00000161Centre of Molecular Immunology (CIM)579